Poul Erik Jakobsen
Overview
Explore the profile of Poul Erik Jakobsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roikjer J, Kvist A, Nikontovic A, Jakobsen P, Vestergaard P, Studstrup M, et al.
Ann Vasc Surg
. 2024 Aug;
109:407-413.
PMID: 39096952
Background: Preventing lower-extremity amputations (LEAs) is pivotal. In the present study, we aimed to examine the recent trends in nontraumatic LEAs seen in the Northern Danish Region. Methods: Using data...
2.
Arendt Nielsen T, Andersen C, Vorum H, Riahi S, Sega R, Drewes A, et al.
Invest Ophthalmol Vis Sci
. 2022 Aug;
63(9):21.
PMID: 35980646
Purpose: The superior and inferior tarsal muscles are sympathetically innervated smooth muscles. Long-term diabetes often leads to microvascular complications, such as, retinopathy and autonomic neuropathy. We hypothesized that diabetes induces...
3.
Arendt Nielsen T, Sega R, Andersen C, Vorum H, Drewes A, Jakobsen P, et al.
J Ocul Pharmacol Ther
. 2021 Dec;
38(1):114-121.
PMID: 34918951
Liraglutide treatment has shown promising anti-inflammatory and nerve regenerative results in preclinical and clinical trials. We sought to assess if liraglutide treatment would induce nerve regeneration through its anti-inflammatory and...
4.
Skovlund S, Troelsen L, Noergaard L, Pietraszek A, Jakobsen P, Ejskjaer N
JMIR Form Res
. 2021 Nov;
5(11):e28329.
PMID: 34730545
Background: Improvements in the digital capabilities of health systems provide new opportunities for the integration of patient-reported outcome (PRO) solutions in routine care, which can facilitate the delivery of person-centered...
5.
Hansen T, Muthulingam J, Brock B, Drewes A, Juhl A, Vorum H, et al.
Neurosci Res
. 2021 Oct;
176:66-72.
PMID: 34656646
In this study we investigated brain morphology in adults with diabetic neuropathy. We aimed to characterize gray matter volume (GMV) and cortical thickness, and to explore associations between whole brain...
6.
Skovlund S, Troelsen L, Klim L, Jakobsen P, Ejskjaer N
Res Involv Engagem
. 2021 Sep;
7(1):62.
PMID: 34507618
Background: This study sought to utilise participatory research methods to identify the perspectives of people with diabetes regarding which diabetes outcomes were most important to them. These findings were then...
7.
Nissen T, Meldgaard T, Nedergaard R, Juhl A, Jakobsen P, Karmisholt J, et al.
J Diabetes Complications
. 2020 Jun;
34(9):107614.
PMID: 32571684
Aims: We hypothesized that adults with type 1 diabetes and severe polyneuropathy have alterations in neuronal transmission at different anatomical levels. The aims were to investigate upstream sensory neuronal activation...
8.
Nedergaard R, Nissen T, Morch C, Meldgaard T, Juhl A, Jakobsen P, et al.
J Clin Neurophysiol
. 2020 Jun;
38(4):299-305.
PMID: 32501945
Purpose: Comprehensive evaluation of the upstream sensory processing in diabetic symmetrical polyneuropathy (DSPN) is sparse. The authors investigated the spinal nociceptive withdrawal reflex and the related elicited somatosensory evoked cortical...
9.
Okdahl T, Brock C, Floyel T, Wegeberg A, Jakobsen P, Ejskjaer N, et al.
Clin Endocrinol (Oxf)
. 2020 Jun;
93(4):419-428.
PMID: 32497255
Objective: Distal symmetrical polyneuropathy (DSPN) is a severe common long-term complication of type 1 diabetes caused by impaired sensory-motor nerve function. As chronic low-grade inflammation may be involved in the...
10.
Wegeberg A, Hansen C, Farmer A, Karmisholt J, Drewes A, Jakobsen P, et al.
United European Gastroenterol J
. 2020 May;
8(6):695-704.
PMID: 32390563
Background: Glucagon-like peptide-1 receptor agonists, such as liraglutide, reduce hyperglycaemia and induce weight loss and are used as a treatment in diabetes. However, common adverse effects include nausea, loss of...